Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Price:
918.3
INR
10.15%
Market Closed
Market Cap:
145.5B
INR
Cash Flow Statement
Cash Flow Statement
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
Currency: INR
Millions
TTM
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
12 105
|
16 463
|
8 711
|
8 899
|
6 304
|
2 813
|
278
|
455
|
1 705
|
6 914
|
|
| Depreciation & Amortization |
4 619
|
6 900
|
4 516
|
4 113
|
3 817
|
3 824
|
5 540
|
5 518
|
3 819
|
3 777
|
|
| Other Non-Cash Items |
2 988
|
4 350
|
6 058
|
5 858
|
1 978
|
2 204
|
2 288
|
2 041
|
3 735
|
(124)
|
|
| Cash Taxes Paid |
2 487
|
3 008
|
3 941
|
2 831
|
1 941
|
2 526
|
2 043
|
1 691
|
2 077
|
2 385
|
|
| Cash Interest Paid |
3 250
|
3 110
|
2 922
|
2 190
|
1 349
|
2 024
|
2 342
|
2 090
|
2 437
|
2 488
|
|
| Change in Working Capital |
(4 283)
|
(12 117)
|
(2 212)
|
(3 618)
|
(3 724)
|
(3 918)
|
(1 500)
|
1 821
|
454
|
(2 891)
|
|
| Cash from Operating Activities |
15 429
N/A
|
15 596
+1%
|
17 073
+9%
|
15 252
-11%
|
8 375
-45%
|
4 923
-41%
|
6 607
+34%
|
9 836
+49%
|
9 713
-1%
|
7 676
-21%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(5 742)
|
(5 567)
|
(5 275)
|
(5 846)
|
(6 000)
|
(6 520)
|
(8 144)
|
(9 702)
|
(8 977)
|
(10 420)
|
|
| Other Items |
2 472
|
(1 851)
|
(2 115)
|
2 028
|
2 196
|
1 153
|
2 700
|
3 662
|
2 898
|
14 112
|
|
| Cash from Investing Activities |
(3 270)
N/A
|
(7 418)
-127%
|
(7 390)
+0%
|
(3 819)
+48%
|
(3 804)
+0%
|
(5 366)
-41%
|
(5 444)
-1%
|
(6 040)
-11%
|
(6 079)
-1%
|
3 692
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
3
|
3
|
(101)
|
0
|
0
|
0
|
(40)
|
(314)
|
(274)
|
(47)
|
|
| Net Issuance of Debt |
(5 728)
|
(6 451)
|
(14 056)
|
(9 022)
|
1 824
|
1 668
|
1 616
|
982
|
(816)
|
(7 085)
|
|
| Cash Paid for Dividends |
(1 528)
|
(1 533)
|
(15)
|
(803)
|
(801)
|
(105)
|
(801)
|
(1 495)
|
(798)
|
(796)
|
|
| Other |
(3 250)
|
(3 098)
|
(2 922)
|
(2 190)
|
(1 349)
|
(2 024)
|
(2 342)
|
(2 090)
|
(2 437)
|
(2 488)
|
|
| Cash from Financing Activities |
(10 504)
N/A
|
(11 080)
-5%
|
(17 094)
-54%
|
(12 115)
+29%
|
(326)
+97%
|
(461)
-41%
|
(1 567)
-240%
|
(2 918)
-86%
|
(4 325)
-48%
|
(10 416)
-141%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
599
|
357
|
123
|
228
|
573
|
787
|
705
|
403
|
116
|
80
|
|
| Net Change in Cash |
2 254
N/A
|
(2 545)
N/A
|
(7 288)
-186%
|
(454)
+94%
|
4 818
N/A
|
(117)
N/A
|
301
N/A
|
1 281
+326%
|
(575)
N/A
|
1 032
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
9 687
N/A
|
10 029
+4%
|
11 798
+18%
|
9 406
-20%
|
2 375
-75%
|
(1 597)
N/A
|
(1 538)
+4%
|
133
N/A
|
736
+453%
|
(2 744)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
